Groundbreaking studies clarify mechanisms of cancer progression and therapeutic resistance. Research reveals branched-chain amino acids fuel tumor growth, while a long non-coding RNA network influences colorectal cancer progression and immune resistance. Additional work identifies biomarkers predictive of gastric and breast cancer metastasis and elucidates novel interactions driving tumor development. These advances refine molecular targets and biomarker panels for precision oncology.